DEN-15829-30738
4 vaccinations
8 coded responses
47 check-ins
7 free-text entries
1 call case
- Sex
- —
- Age at first dose
- 36-40
- ZIP prefix
- 221 / VA
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-03-12
Registered in v-safe
-
2021-03-12
Dose 1 — Pfizer-BioNTech
-
2021-03-12
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Nausea, Diarrhea, Abdominal painAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, NauseaAdult check-in
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, NauseaAdult check-in
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-26
- 2021-04-11
-
2021-04-13
Dose 2 — Pfizer-BioNTech
-
2021-04-13
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-04-14
- 2021-04-15
- 2021-04-16
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-04-19
- 2021-04-22
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
-
2021-05-25
Survey response — day 42, dose 2MedDRA: Hypersensitivity — Feeling: GoodFree text: AllergiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-13
-
2021-10-12
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, Respiratory syncytial virus infection — Feeling: GoodFree text: Minor cold, and RSVMedDRA releases: 2024-11 · check-in free text available
-
2021-10-13
Dose 3 — Pfizer-BioNTech
- 2021-10-14
-
2021-10-15
Survey response — days 1–6 daily, dose 3MedDRA: Insomnia — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body achesFree text: InsomniaMedDRA releases: 2024-11 · check-in free text available
-
2021-10-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, NauseaAdult check-in
- 2021-10-17
- 2021-10-18
-
2021-10-19
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-11
- 2021-11-17
-
2021-11-24
Survey response — day 42, dose 3MedDRA: Anxiety, Depression, Fatigue — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Anxiety, depression, fatigue. All attributable to other causes.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-24
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-01-12
Survey response — 3 months, dose 3MedDRA: Hand-foot-and-mouth disease, Influenza — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Hand, food, and mouth disease. Probable flu.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-15
- 2022-04-13
-
2022-09-08
Dose 4 — Moderna
- 2022-09-21
- 2022-09-22
- 2022-09-29
-
2022-10-06
Survey response — day 28, dose 4MedDRA: Arthralgia, Arthropathy — Feeling: FairFree text: Joint pain in the shoulder where the vaccine was administered. Usually faint, but occasionally problematic and occasionally also manifesting in my elbow, wrist, and fingers on my right arm. I would see a doctor if I could get in quickly.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-13
- 2022-10-20
-
2022-12-08
Survey response — 3 months, dose 4MedDRA: Bacterial infection, Sinusitis, Viral infection — Feeling: Fair · Be unable to work or attend schoolFree text: Minor viral infection leading to secondary bacterial sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2023-03-09
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech | |
| 3 | 2021-10-13 | Pfizer-BioNTech | No |
| 4 | 2022-09-08 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — day 42, dose 2
Symptoms: Allergies
Release 10 — 6 months, dose 2
Symptoms: Minor cold, and RSV
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Insomnia
Release 10 — day 42, dose 3
Symptoms: Anxiety, depression, fatigue. All attributable to other causes.
Release 10 — 3 months, dose 3
Symptoms: Hand, food, and mouth disease. Probable flu.
Release 12 — day 28, dose 4
Symptoms: Joint pain in the shoulder where the vaccine was administered. Usually faint, but occasionally problematic and occasionally also manifesting in my elbow, wrist, and fingers on my right arm. I would see a doctor if I could get in quickly.
Release 12 — 3 months, dose 4
Symptoms: Minor viral infection leading to secondary bacterial sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Arthropathy | · | · | ✓ |
| SD | Bacterial infection | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Depression | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release